Literature DB >> 17293910

Risk factors for poor immune response to influenza vaccination in elderly people.

N C J Bellei1, E Carraro, A Castelo, C F H Granato.   

Abstract

Influenza vaccination of elderly people is efficacious and cost effective for the prevention of influenza and its complications. Some studies have pointed out low immunogenicity in this group. Health status has been poorly investigated as a risk factor that may influence the immune response to influenza vaccine. We established an immunization response study of a highly-matched elderly population in a nursing home. One-hundred-twenty subjects of Ashkenazian origin had their vaccine-induced antibody response assessed. Good response was obtained in 30.8% (37/120), and 31.7% (38/120) did not react. A lack of good response was found to be associated with dementia (P=0.016) in a multivariate analysis. In addition to dementia, malnutrition was frequently observed among poor responders, suggesting that these factors should be considered in vaccination studies. Chemoprophylaxis in addition to vaccination for elderly presenting dementia should be considered, particularly for those people living nursing homes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17293910     DOI: 10.1590/s1413-86702006000400011

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  10 in total

Review 1.  Global burden of influenza as a cause of cardiopulmonary morbidity and mortality.

Authors:  William A Fischer; Michelle Gong; Satish Bhagwanjee; Jonathan Sevransky
Journal:  Glob Heart       Date:  2014-10-31

2.  Serum C-Reactive Protein and Congestive Heart Failure as Significant Predictors of Herpes Zoster Vaccine Response in Elderly Nursing Home Residents.

Authors:  Chris P Verschoor; Alina Lelic; Robin Parsons; Carole Evelegh; Jonathan L Bramson; Jennie Johnstone; Mark B Loeb; Dawn M E Bowdish
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

3.  Immunogenicity of influenza A(H1N1)pdm09 vaccine in patients with diabetes mellitus: with special reference to age, body mass index, and HbA1c.

Authors:  Yumi Egawa; Satoko Ohfuji; Wakaba Fukushima; Yuko Yamazaki; Tomoaki Morioka; Masanori Emoto; Kazuhiro Maeda; Masaaki Inaba; Yoshio Hirota
Journal:  Hum Vaccin Immunother       Date:  2014-04-09       Impact factor: 3.452

Review 4.  Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective.

Authors:  Charles R Beck; Bruce C McKenzie; Ahmed B Hashim; Rebecca C Harris; Arina Zanuzdana; Gabriel Agboado; Elizabeth Orton; Laura Béchard-Evans; Gemma Morgan; Charlotte Stevenson; Rachel Weston; Mitsuru Mukaigawara; Joanne Enstone; Glenda Augustine; Mobasher Butt; Sophie Kim; Richard Puleston; Girija Dabke; Robert Howard; Julie O'Boyle; Mary O'Brien; Lauren Ahyow; Helene Denness; Siobhan Farmer; Jose Figureroa; Paul Fisher; Felix Greaves; Munib Haroon; Sophie Haroon; Caroline Hird; Rachel Isba; David A Ishola; Marko Kerac; Vivienne Parish; Jonathan Roberts; Julia Rosser; Sarah Theaker; Dean Wallace; Neil Wigglesworth; Liz Lingard; Yana Vinogradova; Hiroshi Horiuchi; Javier Peñalver; Jonathan S Nguyen-Van-Tam
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

Review 5.  Potential Impact of Co-Infections and Co-Morbidities Prevalent in Africa on Influenza Severity and Frequency: A Systematic Review.

Authors:  Adam L Cohen; Meredith McMorrow; Sibongile Walaza; Cheryl Cohen; Stefano Tempia; Marissa Alexander-Scott; Marc-Alain Widdowson
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

6.  Determining the Provincial and National Burden of Influenza-Associated Severe Acute Respiratory Illness in South Africa Using a Rapid Assessment Methodology.

Authors:  Jillian Murray; Adam Cohen; Sibongile Walaza; Michelle Groome; Shabir Madhi; Ebrahim Variava; Kathleen Kahn; Halima Dawood; Stefano Tempia; Akhona Tshangela; Marietje Venter; Daniel Feikin; Cheryl Cohen
Journal:  PLoS One       Date:  2015-07-08       Impact factor: 3.240

7.  Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C.

Authors:  Satoko Ohfuji; Wakaba Fukushima; Akihiro Tamori; Kazuhiro Maeda; Akiko Maeda; Yoshio Hirota
Journal:  Influenza Other Respir Viruses       Date:  2012-08-16       Impact factor: 4.380

Review 8.  Does Vitamin D Deficiency Affect the Immunogenic Responses to Influenza Vaccination? A Systematic Review and Meta-Analysis.

Authors:  Ming-Dar Lee; Chao-Hsu Lin; Wei-Te Lei; Hung-Yang Chang; Hung-Chang Lee; Chun-Yan Yeung; Nan-Chang Chiu; Hsin Chi; Jui-Ming Liu; Ren-Jun Hsu; Yu-Jyun Cheng; Tzu-Lin Yeh; Chien-Yu Lin
Journal:  Nutrients       Date:  2018-03-26       Impact factor: 5.717

9.  The Saudi Thoracic Society guidelines for influenza vaccinations.

Authors:  Mohammed O Zeitouni; Ali M Al Barrak; Mohamed S Al-Moamary; Nasser S Alharbi; Majdy M Idrees; Abdullah A Al Shimemeri; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2015 Oct-Dec       Impact factor: 2.219

Review 10.  The influence of prebiotic or probiotic supplementation on antibody titers after influenza vaccination: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Wei-Te Lei; Chien-Yu Lin; Tzu-Lin Yeh; Pei-Ching Shih; Shu-Jung Liu; Chao-Hsu Lin; Jui-Ming Liu
Journal:  Drug Des Devel Ther       Date:  2018-01-25       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.